2131 - 2140 of 8654 Results
Title
Year
-
OPENTitle: A proteome-wide quantitative platform for nanoscale spatially resolved extraction of membrane proteins into native nanodiscsJournal Name: Nature MethodsPublisher: Springer Science and Business Media LLCVol: 22Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41592-024-02517-xBest OA location URL: https://doi.org/10.1038/s41592-024-02517-xCitation Count: 1
-
OPENTitle: Bidirectional relationship between depression and activities of daily living and longitudinal mediation of cognitive function in patients with Parkinson’s diseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 17Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2025.1513373Best OA location URL: https://doi.org/10.3389/fnagi.2025.1513373Citation Count: 2
-
OPENTitle: Comparative analysis of AAV serotypes for transduction of olfactory sensory neuronsJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 19Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2025.1531122Best OA location URL: https://doi.org/10.3389/fnins.2025.1531122Citation Count: 0
-
OPENTitle: Baseline liver fibrosis-4 score correlates to the progression of anxiety and cognitive impairment in patients with Parkinson’s diseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 17Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2025.1501319Best OA location URL: https://www.frontiersin.org/journals/aging-neuroscience/articles/10.3389/fnagi.2025.1501319/pdfCitation Count: 0
-
OPENTitle: Identifying gait differences between Alzheimer's disease and dementia with Lewy bodies and their associations with regional amyloid depositionJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 21Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.14351Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11815204Citation Count: 2
-
OPENTitle: Alzheimer's disease‐associated CD83(+) microglia are linked with increased immunoglobulin G4 and human cytomegalovirus in the gut, vagal nerve, and brainJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 21Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/alz.14401Best OA location URL: https://doi.org/10.1002/alz.14401Citation Count: 2
- Changes in Action Tremor in Parkinson's Disease over Time: Clinical and Neuroimaging Correlates2024OPENTitle: Changes in Action Tremor in Parkinson's Disease over Time: Clinical and Neuroimaging CorrelatesJournal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.30081Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11832800Citation Count: 0
- Comparative safety of antimuscarinics versus mirabegron for overactive bladder in Parkinson disease2023OPENTitle: Comparative safety of antimuscarinics versus mirabegron for overactive bladder in Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 115Issue #:Start Page: 105822End Page: 105822Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105822Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10853986Citation Count: 3
-
OPENTitle: Functional efficacy of the MAO-B inhibitor safinamide in murine substantia nigra pars compacta dopaminergic neurons in vitro: A comparative study with tranylcypromineJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 128Issue #:Start Page: 107158End Page: 107158Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107158Best OA location URL: https://doi.org/10.1016/j.parkreldis.2024.107158Citation Count: 2
-
OPENTitle: CYP1B1-RMDN2 Alzheimer’s disease endophenotype locus identified for cerebral tau PETJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-52298-2Best OA location URL: https://doi.org/10.1038/s41467-024-52298-2Citation Count: 4